CIK: 0001664974 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $129,909 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,281 | $60,411 | 46.5% | $5.61 | -17.5% | COM CL A | 30049H102 |
| RKLB | Rocket Lab Corp | 1,083,053 | $38,741 | 29.8% | $24.48 | 0.0% | COM | 773121108 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $30,062 | 23.1% | $18.82 | -73.9% | CL A | 75629V104 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $651 | 0.5% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $44 | 0.0% | $5.56 | +94.8% | SHS | G76279101 |